Measuring perfusion and permeability in renal cell carcinoma with dynamic contrast‐enhanced MRI: A pilot study
Open Access
- 23 January 2010
- journal article
- research article
- Published by Wiley in Journal of Magnetic Resonance Imaging
- Vol. 31 (2), 490-501
- https://doi.org/10.1002/jmri.22028
Abstract
Purpose: To retrospectively assess an improved quantitative methodology with separate assessment of perfusion and permeability for characterization of primary renal cell carcinoma (RCC) and monitoring antiangiogenic treatment. Materials and Methods: Fifteen RCC patients before surgery, 6 RCC patients before and after neoadjuvant antiangiogenic therapy, and 15 patients without renal disease underwent dynamic contrast‐enhanced (DCE)‐MRI of the kidney with integrated retrospective respiratory triggering and an individual arterial input function. Tracer kinetic analysis was performed with a two‐compartment‐filtration‐model for the kidney data and a two‐compartment‐exchange‐model for the tumor data, providing four independent parameters: the perfusion‐parameters plasma flow (FP) and plasma volume (VP), and the permeability‐parameters extraction flow (FE) and extravascular‐extracellular volume (VE). Results: In tumors FP and FE were significantly lower than in normal kidneys. Tracer kinetic analysis displayed hemodynamic alteration caused by vessel infiltration or necrosis. Papillary RCC could be differentiated from clear‐cell variants by a distinct perfusion pattern. In antiangiogenically treated RCC VE was not significantly decreased, while the perfusion parameters VP and FP were significantly diminished. Conclusion: DCE‐MRI with integrated motion compensation enables evaluation of primary RCC and detects distinct perfusion patterns. Quantification with a two‐compartment‐exchange‐model produces a separate perfusion‐ and permeability characterization and may become a diagnostic tool to monitor antiangiogenic treatment. J. Magn. Reson. Imaging 2010; 31: 490–501.Keywords
This publication has 26 references indexed in Scilit:
- Renal Cell Carcinoma: Dynamic Contrast-enhanced MR Imaging for Differentiation of Tumor Subtypes—Correlation with Pathologic FindingsRadiology, 2009
- Differentiation between Diverticulitis and Colorectal Cancer: Quantitative CT Perfusion Measurements versus Morphologic Criteria—Initial ExperienceRadiology, 2007
- Cancer Statistics, 2007CA: A Cancer Journal for Clinicians, 2007
- Food and Drug Administration Drug Approval Summary: Sunitinib Malate for the Treatment of Gastrointestinal Stromal Tumor and Advanced Renal Cell CarcinomaThe Oncologist, 2007
- Targeted Agents for the Treatment of Advanced Renal Cell CarcinomaCurrent Drug Targets, 2005
- Injection of Immature Dendritic Cells into Adjuvant-Treated Skin Obviates the Need for Ex Vivo MaturationThe Journal of Immunology, 2003
- Randomized Study of High-Dose and Low-Dose Interleukin-2 in Patients With Metastatic Renal CancerJournal of Clinical Oncology, 2003
- Regression of Metastatic Renal-Cell Carcinoma after Nonmyeloablative Allogeneic Peripheral-Blood Stem-Cell TransplantationNew England Journal of Medicine, 2000
- New Guidelines to Evaluate the Response to Treatment in Solid TumorsJNCI Journal of the National Cancer Institute, 2000
- CT Measurement of Perfusion and Permeability Within Lymphoma Masses and Its Ability to Assess Grade, Activity, and Chemotherapeutic ResponseJournal of Computer Assisted Tomography, 1999